Public procurement / RFP

Due to clarifications and questions, the Contracting Authority has decided to extend the deadline for submitting bids in the ZO-03-2020 inquiry.

The updated file can be found below:

ZO-03-2020_ang_27_11_2020

Due to clarifications and questions, the Contracting Authority has decided to extend the deadline for submitting bids in the ZO-02-2020 inquiry.

The updated file can be found below:

ZO-02-2020_ANG_27_11_2020

To whom it may concern,

Below please find the explanations to request for proposals ZO-02-2020 as well as the updated request for proposals

Wyjasnienia tresci zapytania ZO-03-2020_eng

ZO-03-2020_ang_24_11_2020_po wyjanieniach_opublikowane

To whom it may concern,

Below please find the explanations to request for proposals ZO-02-2020 as well as the updated request for proposals

Wyjasnienia tresci zapytania ZO-02-2020_eng

ZO-02-2020_ANG_24_11_2020_po wyjasnieniach-opublikowane

05.11.2020

Starting the task under the project no. POIR.01.01.01-00-0123/16 entitled “Development of selective endometriosis therapy based on mesprogestins” we invite to participate in request for proposals for .
“A 13-week toxicity study in female Cynomolgus monkeys for a new active substance (low molecular weight compound) according to ICH Guidelines M3 (R2).”

The subject of the contract is a 13-week toxicity study in Cynomolgus monkey females for EC313 in accordance with ICH M3 (R2) guidelines which is the subject of the project entitled “Development of selective endometriosis therapy based on mesoprogestagens”. For a detailed scope of order, see Annex 3 to the Enquiry.

ZO-02-2020_ANG

Baza konkurencyjności number: 2020-7912-15684

Offers submission deadline: 2020-12-08 18:00:00

05.11.2020

Starting the task under the project no. POIR.01.01.01-00-0123/16 entitled “Development of selective endometriosis therapy based on mesprogestins” we invite to participate in request for proposals for .
“A 13-week toxicity study in female Cynomolgus monkeys for a new active substance (low molecular weight compound) according to ICH Guidelines M3 (R2).”

The subject of the contract is a 13-week toxicity study in Cynomolgus monkey females for EC313 in accordance with ICH M3 (R2) guidelines which is the subject of the project entitled “Development of selective endometriosis therapy based on mesoprogestagens”. For a detailed scope of order, see Annex 3 to the Enquiry.

ZO-03-2020_ang

Baza konkurencyjności number: 2020-7912-15664

Offers submission deadline: 2020-12-08 18:00:00

Commencing a job within project no, POIR.01.01.01-00-0123/16 entitled “Development of Selective Endometriosis Therapy Based on Mesoprogestins” we invite to submit a tender for reproductive toxicology studies

The offer file is placed belowZO-01-2020ang

Commencing a job within project no, POIR.01.01.01-00-0123/16 entitled “Development of Selective Endometriosis Therapy Based on Mesoprogestins” we invite to submit a tender for reproductive toxicology studies

The offer file is placed below

Attachment no 4 ZO-07-2019 ang

ZO-07-2019ang

Commencing a job within project no, POIR.01.01.01-00-0123/16 entitled “Development of Selective Endometriosis Therapy Based on Mesoprogestins” we invite to submit a tender for MICRONIZATION PROCESS OF EC313 COMPOUND

The offer file is placed below

ZO-06-2019 eng_published

Commencing a research task within project no, POIR.01.01.01-00-0123/16 entitled“Development of Selective Endometriosis Therapy Based on Mesoprogestins” we invite to submit a tender for reproductive toxicology studies.

Below please find the documents

Attachemnt_no_5_ZO-03-2019

ZO-03-2019eng